The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Arrhythmias and Conduction Defects as Presenting Symptoms of Fatty Acid Oxidation Disorders in Children
Open accessAbstract
Background —The clinical manifestations of inherited disorders of fatty acid oxidation vary according to the enzymatic defect. They may present as isolated cardiomyopathy, sudden death, progressive skeletal myopathy, or hepatic failure. Arrhythmia is an unusual presenting symptom of fatty acid oxidation deficiencies. Methods and Results —Over a period of 25 years, 107 patients were diagnosed with an inherited fatty acid oxidation disorder. Arrhythmia was the predominant presenting symptom in 24 cases. These 24 cases included 15 ventricular tachycardias, 4 atrial tachycardias, 4 sinus node dysfunctions with episodes of atrial tachycardia, 6 atrioventricular blocks, and 4 left bundle-branch blocks in newborn infants. Conduction disorders and atrial tachycardias were observed in patients with defects of long-chain fatty acid transport across the inner mitochondrial membrane (carnitine palmitoyl transferase type II deficiency and carnitine acylcarnitine translocase deficiency) and in patients with trifunctional protein deficiency. Ventricular tachycardias were observed in patients with any type of fatty acid oxidation deficiency. Arrhythmias were absent in patients with primary carnitine carrier, carnitine palmitoyl transferase I, and medium chain acyl coenzyme A dehydrogenase deficiencies. Conclusions —The accumulation of arrhythmogenic intermediary metabolites of fatty acids, such as long-chain acylcarnitines, may be responsible for arrhythmias. Inborn errors of fatty acid oxidation should be considered in unexplained sudden death or near-miss in infants and in infants with conduction defects or ventricular tachycardia. Diagnosis can be easily ascertained by an acylcarnitine profile from blood spots on filter paper.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Millington, D. S., Kodo, N., Norwood, D. L., & Roe, C. R. (1990) · Journal of Inherited Metabolic Disease · doi:10.1007/bf01799385 · Cited by 571
Inborn Metabolic Diseases: Diagnosis and Treatment
(2012) · doi:10.1007/978-3-642-15720-2 · Cited by 377
Recognition and management of fatty acid oxidation defects: A series of 107 patients
Saudubray, J. M., Martin, D., De Lonlay, P., Touati, G., Poggi‐Travert, F., Bonnet, D., Jouvet, P., Boutron, M., Slama, A., Vianey‐Saban, C., et al. (1999) · Journal of Inherited Metabolic Disease · doi:10.1023/a:1005556207210 · Cited by 333
Self-citationCongenital heart block in newborns of mothers with connective tissue disease.
McCue, C. M., Mantakas, M. E., Tingelstad, J. B., & Ruddy, S. (1977) · Circulation · doi:10.1161/01.cir.56.1.82 · Cited by 331
Long-chain fatty acids activate calcium channels in ventricular myocytes.
Huang, J. M., Xian, H., & Bacaner, M. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.14.6452 · Cited by 303
Epstein, F. H., Kelly, D. P., & Strauss, A. W. (1994) · New England Journal of Medicine · doi:10.1056/nejm199403313301308 · Cited by 257
Chronic cardiomyopathy and weakness or acute coma in children with a defect in carnitine uptake
Stanley, C. A., DeLeeuw, S., Coates, P. M., Vianey‐Liaud, C., Divry, P., Bonnefont, J., Saudubray, J., Haymond, M., Trefz, F. K., Breningstall, G. N., et al. (1991) · Annals of Neurology · doi:10.1002/ana.410300512 · Cited by 213
Self-citationInhibition of carnitine palmitoyltransferase-1 in rat heart and liver by perhexiline and amiodarone
Kennedy, J. A., Unger, S. A., & Horowitz, J. D. (1996) · Biochemical Pharmacology · doi:10.1016/0006-2952(96)00204-3 · Cited by 209
Prophylaxis of early ventricular fibrillation by inhibition of acylcarnitine accumulation.
Corr, P. B., Creer, M. H., Yamada, K. A., Saffitz, J. E., & Sobel, B. E. (1989) · Journal of Clinical Investigation · doi:10.1172/jci113978 · Cited by 206
Boles, R. G., Buck, E. A., Blitzer, M. G., Platt, M. S., Cowan, T. M., Martin, S. K., Yoon, H.-R., Madsen, J. A., Reyes-Mugica, M., & Rinaldo, P. (1998) · The Journal of Pediatrics · doi:10.1016/s0022-3476(98)70385-3 · Cited by 202
Cited by
A general introduction to the biochemistry of mitochondrial fatty acid β‐oxidation
Houten, S. M., & Wanders, R. J. A. (2010) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-010-9061-2 · Cited by 1,020
The Biochemistry and Physiology of Mitochondrial Fatty Acid β-Oxidation and Its Genetic Disorders
Houten, S. M., Violante, S., Ventura, F. V., & Wanders, R. J. A. (2016) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021115-105045 · Cited by 920
Towbin, J. A., McKenna, W. J., Abrams, D. J., Ackerman, M. J., Calkins, H., Darrieux, F. C. C., Daubert, J. P., de Chillou, C., DePasquale, E. C., Desai, M. Y., et al. (2019) · Heart Rhythm · doi:10.1016/j.hrthm.2019.05.007 · Cited by 846
Blair, E. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.11.1215 · Cited by 528
Acylcarnitines: Nomenclature, Biomarkers, Therapeutic Potential, Drug Targets, and Clinical Trials
Dambrova, M., Makrecka-Kuka, M., Kuka, J., Vilskersts, R., Nordberg, D., Attwood, M. M., Smesny, S., Sen, Z. D., Guo, A. C., Oler, E., et al. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.121.000408 · Cited by 507
Metadata
- Authors
- Bonnet, D., Martin, D., de Lonlay, P., Villain, E., Jouvet, P., Rabier, D., Brivet, M., & Saudubray, J.-M.
- Venue
- Circulation
- Published
- 1999-11-30
- Volume
- 100
- Issue
- 22
- Pages
- 2248-2253
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2101527214
- Cited by
- 311
- References
- 21
- FWCI
- 7.40
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Arrhythmias and Conduction Defects as Presenting Symptoms of Fatty Acid Oxidation Disorders in Children. https://app.cochat.ai/papers/10.1161/01.cir.100.22.2248
- The paper
- Bonnet, D., Martin, D., de Lonlay, P., Villain, E., Jouvet, P., Rabier, D., Brivet, M., & Saudubray, J.-M. (1999). Arrhythmias and Conduction Defects as Presenting Symptoms of Fatty Acid Oxidation Disorders in Children. Circulation. https://doi.org/10.1161/01.cir.100.22.2248
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.